IMMUNOSTEP

At immunostep we have been innovating since 2001 to develop comprehensive products that contribute to improve performance in key areas of clinical research and diagnostic development. Our goal is to improve research and diagnostic performance by innovating and adapting new technology to collaborate building meaningful clinical investigation. We work to achieve customer satisfaction through quality and differentiation of our products. We are constantly learning and developing as a company and, in the same way, we expect our products and our way of working to be constantly improving for the benefit of all our collaborators

Immunostep operates in the Biotechnology industry.

Immunostep's revenue is 11m - 100m

Immunostep has 11 - 50 employees.